biospecimen__admin__batch_number	377.51.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	9FAE46F1-0776-43A9-8EA3-0EA4722EA107
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-MR-A8JO-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-MR-A8JO-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-MR-A8JO-01A
biospecimen__bio__biospecimen_barcode_bottom	0164083074
biospecimen__bio__day_of_creation	03
biospecimen__bio__day_of_shipment	29
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	12
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-MR-A8JO.DA03F6F5-2579-45B7-954B-8C0F8EFD0F75.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A36A
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.00
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-MR-A8JO
biospecimen__shared__patient_id	A8JO
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	AC2CF4FA-9E6E-4ED6-AC1E-247D5655011C
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.9
clinical__chol_lihc_shared__albumin_result_specified_value	4.1
clinical__chol_lihc_shared__albumin_result_upper_limit	5.1
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	34
clinical__clin_shared__bcr_followup_barcode	TCGA-MR-A8JO-F58923
clinical__clin_shared__bcr_followup_uuid	3A733C3A-32ED-48D4-8AAF-C4897EF1A87C
clinical__clin_shared__day_of_form_completion	9
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	10
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	162
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Fibrolamellar Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	00bff545-8aba-4c63-9982-a59c61168cc4
gdc__aliquots__concentration	0.15
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-MR-A8JO-01A-12R-A36A-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	65433be3-d515-4fae-8847-9909becc4b54
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	968bc9be-c393-4407-ac3a-0475bbb5af2a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	8574d285-e02a-4d2b-931b-73556a9fda02
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:31:12.037302-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	d6ead212-02a9-5251-8310-02fde92b80a3
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1979
gdc__diagnoses__age_at_diagnosis	12669
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-12669.0
gdc__diagnoses__days_to_last_follow_up	330.0
gdc__diagnoses__diagnosis_id	f20df12e-d9f7-5b08-bd89-979ee318b21e
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8171/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma fibrolamellar
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.4277384423157
gdc__exposures__exposure_id	6f5d18bf-02c1-50cb-8fed-748fc02f5b76
gdc__exposures__height	196.0
gdc__exposures__weight	90.0
gdc__file_id	1fd634cc-f322-4294-8f84-c1d36f1bd926
gdc__file_name	3964db61-d2f1-43c1-ae2d-76be0e2908a4.mirbase21.mirnas.quantification.txt
gdc__file_size	50221
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	9b5c3ec90f45de4c948ad8a329b8a5fb
gdc__portions__is_ffpe	false
gdc__portions__portion_id	4c9c384a-f515-4453-8468-6533a85b9433
gdc__portions__portion_number	12
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	184
gdc__samples__initial_weight	350.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	DA03F6F5-2579-45B7-954B-8C0F8EFD0F75
gdc__samples__sample_id	f2b89e54-ec4d-4c0a-95db-2435412a7254
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	35.0
gdc__slides__percent_tumor_cells	65.0
gdc__slides__percent_tumor_nuclei	65.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	6c01f86d-b20e-4ee6-9d59-4b8090e2fdd8
gdc__submitter_id	mirna_swap_dr11_110_MirnaExpression698d5882-0a41-47df-8a42-0a9b70669902_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	MR
gdc__tissue_source_site__name	University of Minnesota
gdc__tissue_source_site__tissue_source_site_id	2e3c05db-a4a5-5563-9933-a10940cec98b
gdc__treatments__treatment_id	c814a15b-aa4b-5211-9985-48492ffca1df
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:06:45.750+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/00bff545-8aba-4c63-9982-a59c61168cc4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/00bff545-8aba-4c63-9982-a59c61168cc4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129592
manually_curated__local_md5	40426ca9dabc12f0d5d88a53e263134a
manually_curated__opengdc_download_date	2018-10-16T17:12:56.000052+02:00
manually_curated__opengdc_file_md5	a20d5e202e38e33689383fee6b1c895a
manually_curated__opengdc_file_size	50220
manually_curated__opengdc_id	00bff545-8aba-4c63-9982-a59c61168cc4-meq
manually_curated__origin_file_size	129592
manually_curated__origin_last_modified_date	Tue Oct 16 17:22:00 CEST 2018
manually_curated__origin_md5	40426ca9dabc12f0d5d88a53e263134a
manually_curated__tissue_status	tumoral
